Anti-FZD5/ C2orf31/ HFZ5 monoclonal antibody

Anti-FZD5/ C2orf31/ HFZ5 antibody for FACS & in-vivo assay

Target products collectionGo to FZD5/FZD5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0464-Ab-1/ GM-Tg-hg-MP0464-Ab-2Anti-Human FZD5 monoclonal antibodyHuman
GM-Tg-rg-MP0464-Ab-1/ GM-Tg-rg-MP0464-Ab-2Anti-Rat FZD5 monoclonal antibodyRat
GM-Tg-mg-MP0464-Ab-1/ GM-Tg-mg-MP0464-Ab-2Anti-Mouse FZD5 monoclonal antibodyMouse
GM-Tg-cynog-MP0464-Ab-1/ GM-Tg-cynog-MP0464-Ab-2Anti-Cynomolgus/ Rhesus macaque FZD5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0464-Ab-1/ GM-Tg-felg-MP0464-Ab-2Anti-Feline FZD5 monoclonal antibodyFeline
GM-Tg-cang-MP0464-Ab-1/ GM-Tg-cang-MP0464-Ab-2Anti-Canine FZD5 monoclonal antibodyCanine
GM-Tg-bovg-MP0464-Ab-1/ GM-Tg-bovg-MP0464-Ab-2Anti-Bovine FZD5 monoclonal antibodyBovine
GM-Tg-equg-MP0464-Ab-1/ GM-Tg-equg-MP0464-Ab-2Anti-Equine FZD5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0464-Ab-1/ GM-Tg-hg-MP0464-Ab-2; GM-Tg-rg-MP0464-Ab-1/ GM-Tg-rg-MP0464-Ab-2;
GM-Tg-mg-MP0464-Ab-1/ GM-Tg-mg-MP0464-Ab-2; GM-Tg-cynog-MP0464-Ab-1/ GM-Tg-cynog-MP0464-Ab-2;
GM-Tg-felg-MP0464-Ab-1/ GM-Tg-felg-MP0464-Ab-2; GM-Tg-cang-MP0464-Ab-1/ GM-Tg-cang-MP0464-Ab-2;
GM-Tg-bovg-MP0464-Ab-1/ GM-Tg-bovg-MP0464-Ab-2; GM-Tg-equg-MP0464-Ab-1/ GM-Tg-equg-MP0464-Ab-2
Products NameAnti-FZD5 monoclonal antibody
Formatmab
Target NameFZD5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FZD5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FZD5/ C2orf31/ HFZ5 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0464-Ag-1frizzled class receptor 5 (FZD5) protein
    ORF Viral VectorpGMLPm004353mouse Fzd5 Lentivirus plasmid
    ORF Viral VectorvGMLPm004353mouse Fzd5 Lentivirus particle


    Target information

    Target IDGM-MP0464
    Target NameFZD5
    Gene ID7855,14367,317674,710796,119863906,101097508,538536,100146215
    Gene Symbol and Synonyms5330434N09Rik,C2orf31,Fz-5,Fz5,FZD5,HFZ5,LOC119863906,mFz5
    Uniprot AccessionQ13467,Q8CHL0
    Uniprot Entry NameFZD5_HUMAN,FZD5_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000163251
    Target ClassificationN/A

    The target: FZD5, gene name: FZD5, also named as C2orf31, HFZ5. Members of the 'frizzled' gene family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins.  The FZD5 protein is believed to be the receptor for the Wnt5A ligand. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.